Task: Answer the multiple-choice question.
Question: Which drug exhibits a 23.575% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCNC(=O)NC(=O)C(C)Oc1ccc(C(=O)OC)cc1
b. Cc1cc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)no1
Answer: b. Cc1cc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)no1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)no1
Cc1cc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)no1
5-methyl-N-(4-pyrrolidin-1-ylsulfonylphenyl)-1,2-oxazole-3-carboxamide